期刊名称：IMMUNOLOGY LETTERS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Immunology Letters provides a vehicle for the speedy publication of full-length and short articles, Rapid Notes, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings.
Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion. Within a reference section, new mRNA sequences with unknown function, expressed sequence tags with tissue distribution and novel monoclonal antibody descriptions are considered for publication.
Instructions to Authors
Submission of an article to this journal assumes that the article has not been published elsewhere and is not being considered for publication elsewhere. Submission further assumes that all named authors agree with the submission. Papers should be submitted in English, accompanied by a full title and the fax and telephone numbers and e-mail address of the corresponding author, a summary and key words, and should meet all of the requirements listed under Preparation of Manuscripts below.
Rapid Notes (see below) can be submitted to any member of the Executive Editorial Board, or the Editor-in-Chief, who will arrange for rapid evaluation on a yes/no basis. No compromise, however, will be made with respect to scientific quality. Authors are advised to ascertain the availability of the editor (via E-mail or fax) before submission. If accepted, the paper will be sent immediately to the Publisher and so initial submissions should be accompanied by a statement transferring the copyright to the Publisher and, whenever possible, by an exactly matching copy of the manuscript on diskette. (General guidelines for delivery of manuscripts on diskettes can be found below in the section on Electronic Manuscripts). Details on where to send reprints should also be provided with the submission. 50 Reprints will be provided free of charge but more may be ordered (minimum 100), in which case information on where to send an invoice should also be given.
After acceptance of a manuscript no further changes can be made by the author(s).
2. Types of Articles
- Full length articles - these are full length manuscripts that must fulfil the criteria of manuscript preparation. There is no page limit but articles may be returned for shortening at the Editors' discretion.
- Short articles - as for full length manuscripts but with a page limit of 12 double spaced manuscript pages, including space for figures.
- Current Views - these are (mini)-reviews which may be submitted to any Executive Editor or the Editor-in-Chief, or which may be invited by them.
- Rapid Notes - these are short papers (from 2 to 4 printed pages long) that merit urgent publication.
They should contain new and essentially complete experimental results, clearly presented and documented with a maximum of 3 figures/tables.
[Opinions, hypotheses and commentaries are not acceptable as Rapid Notes but are welcome, and should be submitted as Letters to the Editor].
Rapid Notes should be presented without side-headings but with a concise statement of relevance and importance at the beginning of the article, a clearly recognizable paragraph on materials and methods and a brief summarizing paragraph at the end. The number of references should be no more than 15.
Rapid Notes will usually be published within 6 weeks from submission and no proofs will be sent to the authors; particular attention to the accuracy of the manuscript and the reference list is therefore requested.
- Reference Notes - These are brief - usually 2-3 manuscript pages plus an illustration or table -notes of reference to, for example, new mRNA sequences with unknown function, expressed sequence tags with tissue distribution and novel monoclonal antibody descriptions.
- Letters to the Editor - these are notes sent to any member of the Executive Editorial Board or the Editor-in-Chief, raising a topic for discussion, providing an opinion or an hypothesis, or commentaries on previously published work, etc. Letters to the Editor do not need to follow the General Arrangement instructions given below and should normally not exceed 800 words.
3. Preparation of Manuscripts
(i) Manuscripts should be typewritten, double spaced with wide margins, on one side of the paper only.
(ii) The original and two copies (also of the illustrations) should be submitted to facilitate refereeing, and one copy on floppy disc (see Electronic manuscripts below).
(iii) The title page should include the title of the article, the full names and professional addresses of all of the authors, as well as the full postal address of the corresponding author, including postal code, country, telephone and fax numbers and e-mail address.
(iv) If the paper is part of a numbered series, this should be indicated in a footnote and not in the title.
(v) Line-drawn figures (including graphs) should be in black ink on white paper and must be lettered ready for direct reproduction, OR sharp photoprints of lettered line-drawings may be submitted. It is very important that the drawings themselves AND the lettering are in proportion and large enough to allow for reduction before printing. The amount of reduction that will be made can be judged from the sizes of figures in recent issues of the journal; usually to a single or double column width.
(vi) Graph paper should be ruled in pale blue and any grid lines to be shown should be inked in black.
(vii) Half-tone figures should be submitted as very sharp glossy photoprints with as much contrast as possible, separate from line drawings.
(viii) Reproductions in colour will have to be approved by the Editors. The extra costs of colour reproduction will be charged to the author(s).
(ix) Legends for both line-drawn and half-tone figures should be typed on separate sheets.
(x) Nomenclature and abbreviations: Authors should in general follow internationally agreed rules as set out in Information for Contributors to Biochimica et Biophysica Acta, Elsevier Science B.V., P.O. Box 1345, 1000 BH Amsterdam, The Netherlands, and in Collected Tentative Rules and Recommendations of the Commission on Biochemical Nomenclature, IUPAC-IUB, 1975, American Society of Biological Chemists Inc., 9650 Rockville Pike, Bethesda, MD 20014, USA.
(xi) Typescripts should be carefully checked before submission since alterations after acceptance are not possible.
Electronic manuscripts
Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs.
The preferred storage medium is a 5.25 or 3.5 inch disk in MS-DOS format, although other systems are welcome, e.g. Macintosh (in this case, save your file in the usual manner, do not use the option `save in MS-DOS format'). Please do not split the article into separate files (title page as one file, text as another, etc.). Ensure that the letter `l' and digit `1' (also letter `O' and digit `0') have been used properly, and structure your article (tabs, indents, etc.) consistently. Characters not available on your word processor (Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g., gralpha, @, #, etc., for the Greek letter alpha). Such codes should be used consistently throughout the entire text. Please make a list of such codes and provide a key. Do not allow your word processor to introduce word splits and do not use a `justified' layout. Please adhere strictly to the general instructions on style/arrangement and, in particular, the reference style of the journal. It is very important that you save your file in the native word processor format. If your word processor features the option to save files `in flat ASCII', please do not use it. Format your disk correctly and ensure that only the relevant file (one complete article only) is on the disk. Also, specify the type of computer and word processing package used and label the disk with your name and the name of the file on the disk. After final acceptance, your disk plus one, final, printed and exactly matching version (as a printout) should be submitted together to the accepting Editor. It is important that the file on disk and the printout are identical. Both will then be forwarded by the editor to Elsevier. Further information may be obtained from the Publisher.
4. General arrangement of papers
Papers should be introduced by a title page, as described in 3.iii above. A list of at least 3 keywords should be provided, followed by numbered sections as follows: 1. Summary; 2. Introduction, which should summarize the research problem and the pertinent findings; 3. Materials and Methods or 3. Experimental; 4. Results, and 5. Discussion. Acknowledgements should precede References - they should not be included as footnotes. Letters to the Editor do not need to follow these arrangement instructions. (Mini)-reviews should be introduced by a list of at least 3 keywords, followed by 1. Summary; 2. Introduction, and then headings of the author's choice. References should be included.
5. References
References should be numbered in square brackets sequentially - such as [11], or [13,14], in the order of their citation in the text. The list of references will be printed at the end of the paper.
References to journals should contain the names and initials of all authors, year of publication in parentheses, with the journal title abbreviated according to the List of Serial Title Word Abbreviations (International Serials Data System, Paris), followed by volume number, and page numbers, including the last page of the cited article if possible. References should not be given as 'in press' unless they have been accepted for publication. References to books should include the names and initials of the author(s), year of publication, title of the book, name and initials of editor(s) in parentheses, volume, edition, first and last page numbers, the name and location of the publishing company. No part of the references should be underlined, 'and' should be used instead of '&' and authors' surnames should be in lower case.
Examples:
for journals:
[1] R.M. Zinkernagel, P.C. Doherty, Immunol. Today 18 (1997) 14-17.
for books:
[2] J.R. Kalden, In: J.B. Peter, Y. Shoenfeld, (Eds.), Autoantibodies, Elsevier, 1996, pp. 403-407.
[3] H. Kiyono, J.R. McGhee, (1994) Mucosal Immunology: Intraepithelial Lymphocytes, Raven.
6. Proofs
Proofreading will be undertaken by the Publisher. Unless specifically requested when the paper is submitted, proofs will not be sent to authors. If proofs are supplied they may be checked only for typesetting accuracy: no changes to the original manuscript will be allowed at this stage. The sending of proofs to authors will of course cause delay in publication.
7. Reprints
Authors can keep track on the progress of their accepted article, and set up e-mail alerts informing them of changes to their manuscript's status, by using the "Track a Paper" feature of Elsevier's Author Gateway.
On acceptance of the paper the submitting author will receive an Order Form on which he can order reprints of his article including the 25 free reprints allowed. The Reprints Order Form should be returned as soon as possible to Immunology Letters, Elsevier Science Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland.
8. Editorial matters
Address all queries of an editorial nature to Elsevier Science Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland. Tel.: + 353 61 709600; Fax + 353 61 709100.
Editorial Board
Editor-in-Chief:
V. Horejs¨ª, Institute of Molecular Genetics AS CR, Videnska 1083, 142 20 Prague 4, Czech Republic. E-mail: horejsi@biomed.cas.cz
Executive Board:
G.I. Abelev, Laboratory of Immunochemistry, Cancer Research Centre, Kashirskoye Shosse 24, 115 478 Moscow, Russia.
Fax: (7-095) 324 1205
L.J. Berg, Dept. of Pathology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Fax: +1 508 856-8372
Email:Leslie.Berg@umassmed.edu
K. Eichmann, Max-Planck-Institut f¨¹r Immunologie, St¨¹beweg 51, Postfach 1169, D-79108 Freiburg-Z?hringen, Germany.
Fax: (49-761) 510-8545
P. Erb, Univ. of Basel, Petersplatz, CH-4003, Basel, Switzerland.
Fax: (41-61) 267 3298
Email:erb@ubaclu.unibas.ch
P. Garside, University of Glasgow, Western Infirmary, Dept. of Immunology and Bacteriology, Glasgow G11 6NT, Scotland, UK
J. Gergely, Department of Immunology, L. E?tv?s University, Javorka S.u. 14, 2131 G?d, Hungary.
Fax: (36) 273 451 47
D.E. Isenman, Dept. of Biochemistry, Medical Sciences Bldg., Room 5306, University of Toronto, Toronto, ON, Canada M5S 1A8. E-mail: d.isenman@utoronto.ca
E. Klein, Department of Tumor Biology, Karolinska Institute, Box 280 S-17177, Stockholm, Sweden.
Fax: (46-8) 330498
Email:Eva.Klein@mtc.ki.se
C.J.M. Melief, Academisch Ziekenh. Leiden, Immuno. en Bloedbank, Rijnsburgerweg 10, Gebouw 1, E3-Q, 2333 AA Leiden, The Netherlands.
Fax: (31-71) 5216 751
N. Minato, Kyoto University Graduate School of Medicine, Dept. of Infectious Disease and Immunology, Konoecho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan.
Fax: (81) 75 753 4403
L. Moretta, Instituto Nazionale per la Ricercha sul Cancero, Viale Benedetto XV, No. 10, 16132 Genova, Italy.
Fax: (39-10) 354 123
S. Nedospasov, Laboratory of Cytokine Molecular Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vivalov Str., 117984 Moscow, Russia.
Fax: (1-301) 846 7042
Email:nedospas@ncifcrf.gov
P. Perlmann, Department of Immunology, Biology Building, University of Stockholm, Svante Arrhenius v?g 16-18, S-10691 Stockholm, Sweden.
Fax: (46-8) 157356
A.G. Rolink, Biozentrum, University of Basel, Klingelbergstr. 50-70, CH-4056 Basel, Switzerland
N.H. Ruddle, Dept. of Epidemiology, Public Health and Immunobiology, Head Division of Epidemiology of Microbial Diseases, School of Medicine, 68 College Street, New Haven, CT 06520-8034, USA.
C. Saut¨¨s-Fridman, Professor, Paris 6 University, INSERM U255, Centre de Recherches Biomedicales des Cordeliers, 15 Rue de l'Ecole de Medecine, 75270 Paris Cedex 06. Email: catherine.fridman@u255.bhdc.jussieu.fr
R.E. Schmidt, Medizinische Hochschule Hannover, Klinische Immunologie, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. Fax: 49 (0)5 11 532 9067; E-mail: immunologie@mh-hannover.de
D. Tarlington, Div. of Immunology, PO Royal Melbourne Hospital, Parkville, Victoria 3050, Australia.
Fax: (61-3) 9347 0852
Email:tarlinton@wehi.edu.au
C. Terhorst, Division of Immunology, Beth Israel Hospital, 330 Brookline Avenue, RE204, Boston, MA 02215, USA.
Fax: (1-617) 278-7140
R. Valenta, Institut f¨¹r Pathophysiologie, W?hringer G¨¹rtel 18-20, A-1090 Wien, Austria.
A. Wendel, Universit?t Konstanz, Fakult?t f¨¹r Biologie, Postfach 5560M667, D-78434 Konstanz, Germany.
Fax: (49-7531) 883099
|
